Bio-Techne Corp
F:TE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Bio-Techne Corp (TE1) under the Base Case is 54.86 EUR per share.
Compared with the current market price of 64.94 EUR, the stock appears
Overvalued by 16% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Bio-Techne Does
Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions.
- Headquarters
- United States of America US
- Employees
- 3 100
- IPO date
- Feb 9, 1989
Bio-Techne has a narrow economic moat
Patents on RNAscope probe designs make it harder for rivals to copy some of Bio-Techne’s spatial biology products, and labs may need time and repeat testing to change research workflows built around its validated reagents and instruments. These advantages protect specific products and customer relationships, while many of its markets still have competing suppliers.
Read the full moat analysis
Revenue & Expenses Breakdown
Bio-Techne Corp
Earnings Waterfall
Bio-Techne Corp
Continue TE1 Research
Decided on Bio-Techne? Get an email when TE1 reaches the price you’d buy at. Free with an account.
Other Bio-Techne listings
What is the Intrinsic Value of one TE1 stock?
The intrinsic value for
Bio-Techne Corp (TE1) under the Base Case is 54.86 EUR.
Is TE1 stock undervalued or overvalued?
Compared with the current market price of 64.94 EUR, the stock appears Overvalued by 16% .